company background image
DOCS

Doximity NYSE:DOCS Stock Report

Last Price

US$24.35

Market Cap

US$4.5b

7D

2.7%

1Y

-31.2%

Updated

04 Dec, 2023

Data

Company Financials +

DOCS Stock Overview

Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States.

DOCS fundamental analysis
Snowflake Score
Valuation3/6
Future Growth2/6
Past Performance2/6
Financial Health6/6
Dividends0/6

Rewards

Risk Analysis

No risks detected for DOCS from our risk checks.

Doximity, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Doximity
Historical stock prices
Current Share PriceUS$24.35
52 Week HighUS$40.12
52 Week LowUS$19.71
Beta1.04
1 Month Change11.09%
3 Month Change0.66%
1 Year Change-31.18%
3 Year Changen/a
5 Year Changen/a
Change since IPO-54.06%

Recent News & Updates

Doximity Earnings: Steer Clear Of This Rollercoaster War Of Optimism Vs. Skepticism

Nov 10

Recent updates

Doximity Earnings: Steer Clear Of This Rollercoaster War Of Optimism Vs. Skepticism

Nov 10

Doximity: Adding Value Using AI But Faces Near-Term Risks

Nov 01

Is Doximity, Inc. (NYSE:DOCS) Potentially Undervalued?

Oct 30
Is Doximity, Inc. (NYSE:DOCS) Potentially Undervalued?

Doximity (NYSE:DOCS) Might Be Having Difficulty Using Its Capital Effectively

Sep 25
Doximity (NYSE:DOCS) Might Be Having Difficulty Using Its Capital Effectively

Doximity: Rating Downgrade As Investors Shift Focus To The Near-Term Outlook

Aug 24

Doximity Earnings: Too Many Problems, Sell

Aug 09

A Look At The Intrinsic Value Of Doximity, Inc. (NYSE:DOCS)

Jul 29
A Look At The Intrinsic Value Of Doximity, Inc. (NYSE:DOCS)

Why Doximity, Inc. (NYSE:DOCS) Could Be Worth Watching

Jul 09
Why Doximity, Inc. (NYSE:DOCS) Could Be Worth Watching

Doximity: Continue To See Positive Upside From Current Stock Level

Jul 05

The Returns At Doximity (NYSE:DOCS) Aren't Growing

Jun 21
The Returns At Doximity (NYSE:DOCS) Aren't Growing

Doximity: Digital Health Play With Strong Fundamentals

Jun 21

A Look At The Fair Value Of Doximity, Inc. (NYSE:DOCS)

Apr 07
A Look At The Fair Value Of Doximity, Inc. (NYSE:DOCS)

Doximity (NYSE:DOCS) Is Reinvesting At Lower Rates Of Return

Mar 20
Doximity (NYSE:DOCS) Is Reinvesting At Lower Rates Of Return

Doximity: Good Business But Extremely Overvalued

Feb 18

Doximity Q3 Earnings: Disappointing Results

Feb 10

Calculating The Fair Value Of Doximity, Inc. (NYSE:DOCS)

Dec 25
Calculating The Fair Value Of Doximity, Inc. (NYSE:DOCS)

Doximity: On The Right Path To Further Consolidate Market Share

Dec 22

Here's What's Concerning About Doximity's (NYSE:DOCS) Returns On Capital

Dec 04
Here's What's Concerning About Doximity's (NYSE:DOCS) Returns On Capital

Doximity up 16% after fiscal 2023 Q2 beats, FY revenue range includes consensus

Nov 10

Doximity, down 9%, falls below IPO price

Oct 12

Doximity Appears Well-Positioned But Shares May Be Fully Valued Here

Aug 11

Doximity Non-GAAP EPS of $0.14 beats by $0.03, revenue of $90.6M beats by $0.95M

Aug 04

Unpleasant Surprises Could Be In Store For Doximity, Inc.'s (NYSE:DOCS) Shares

Jul 09
Unpleasant Surprises Could Be In Store For Doximity, Inc.'s (NYSE:DOCS) Shares

Pair Trade: Going Long Doximity And Short Teladoc

Jul 05

Doximity: Slowing Guidance, Stock Drops, But It Oozes Cash Flows

May 18

Doximity: Turning Bullish After Stock Price Correction

Apr 01

Doximity Creates Proximity For Physicians And Rakes Robust Free Cash Flow

Jan 25

Doximity: Better Than Teladoc, But Still Not Worth Buying

Nov 22

Shareholders Can Be Confident That Doximity's (NYSE:DOCS) Earnings Are High Quality

Nov 17
Shareholders Can Be Confident That Doximity's (NYSE:DOCS) Earnings Are High Quality

Doximity: Not Buying At These Prices

Aug 18

Doximity Shows Strength In Its First Public Quarter

Aug 12

Doximity: A Hot IPO Whose Valuation And Profitability Still Leave Upside For Potential Investors

Jul 23

Doximity Stock: Should You Buy This Recent IPO? The Key Is Competition

Jul 13

Doximity: Potential Teladoc Killer

Jun 27

Shareholder Returns

DOCSUS Healthcare ServicesUS Market
7D2.7%1.3%1.1%
1Y-31.2%-5.9%11.7%

Return vs Industry: DOCS underperformed the US Healthcare Services industry which returned -5.9% over the past year.

Return vs Market: DOCS underperformed the US Market which returned 11.7% over the past year.

Price Volatility

Is DOCS's price volatile compared to industry and market?
DOCS volatility
DOCS Average Weekly Movement6.8%
Healthcare Services Industry Average Movement9.2%
Market Average Movement6.1%
10% most volatile stocks in US Market15.5%
10% least volatile stocks in US Market2.9%

Stable Share Price: DOCS is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 7% a week.

Volatility Over Time: DOCS's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2010900Jeff Tangneyhttps://www.doximity.com

Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company’s platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems.

Doximity, Inc. Fundamentals Summary

How do Doximity's earnings and revenue compare to its market cap?
DOCS fundamental statistics
Market CapUS$4.53b
Earnings (TTM)US$123.14m
Revenue (TTM)US$448.31m

36.8x

P/E Ratio

10.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
DOCS income statement (TTM)
RevenueUS$448.31m
Cost of RevenueUS$53.12m
Gross ProfitUS$395.19m
Other ExpensesUS$272.05m
EarningsUS$123.14m

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)0.66
Gross Margin88.15%
Net Profit Margin27.47%
Debt/Equity Ratio0%

How did DOCS perform over the long term?

See historical performance and comparison